| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/28/2009 | WO2009067580A2 Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants |
| 05/28/2009 | WO2009067569A2 Plants with altered root architecture, related constructs and methods involving genes encoding leucine rich repeat kinase (llrk) polypeptides and homologs thereof |
| 05/28/2009 | WO2009067484A2 Regulation of aldosterone synthesis for controlling hypertension |
| 05/28/2009 | WO2009067398A1 Transformation of crambe abyssinica |
| 05/28/2009 | WO2009067243A2 Modulation of cd40 expression |
| 05/28/2009 | WO2009067218A2 Glucoamylase variants with altered properties |
| 05/28/2009 | WO2009067204A2 Method of screening for cancer by detecting mutations in the delta-catenin gene promoter and 5'-untranslated region |
| 05/28/2009 | WO2009067068A1 Method for production and purification of macromolecular complexes |
| 05/28/2009 | WO2009066967A2 Microrna antisense pnas, compositions comprising the same, and methods for using and evaluating the same |
| 05/28/2009 | WO2009066964A1 Method for screening an inhibitory agent of hbv proliferation by using the interaction between hbv capsid and surface proteins based on cellular imaging |
| 05/28/2009 | WO2009066934A2 Methods for improvement of birth rates in canidae on somatic cell nuclear transfer |
| 05/28/2009 | WO2009066927A1 Corynebacteria using carbon sources containing glycerol and process for producing fermentation product using the same |
| 05/28/2009 | WO2009066919A2 Gpt gene as a marker for selecting plant transformant |
| 05/28/2009 | WO2009066867A1 Novel method of designing dna probe chip for room temperature hybridization and the dna probe chip |
| 05/28/2009 | WO2009066802A1 Biological membrane-intrinsic virus-like particle, and method for production thereof |
| 05/28/2009 | WO2009066774A1 Selective expression inhibitor for aurora kinase a and aurora kinase b genes |
| 05/28/2009 | WO2009066761A1 Process for production of non-natural protein having ester bond therein |
| 05/28/2009 | WO2009066758A1 Translation regulation system in cell or artificial cell model by using low-molecular-weight rna |
| 05/28/2009 | WO2009066757A1 Protein-responsive translation control system utilizing rna-protein interaction motif |
| 05/28/2009 | WO2009066702A1 Anti-hiv monoclonal antibody |
| 05/28/2009 | WO2009066695A1 Method of preparing fecal sample, solution for preparing fecal sample and feces collection kit |
| 05/28/2009 | WO2009066673A1 Composition for analysis of nucleic acid |
| 05/28/2009 | WO2009066655A1 Human antibody capable of inducing apoptosis |
| 05/28/2009 | WO2009066513A1 Method of site-selectively cleaving target nucleic acid |
| 05/28/2009 | WO2009066256A1 Rice non-endosperm tissue expression promoter (ostsp i) and the use thereof |
| 05/28/2009 | WO2009066241A1 Antibody fragments inhibiting hiv nef protein |
| 05/28/2009 | WO2009066071A2 Antisense oligonucleotides for the modulation of gene expression and methods relating to the use thereof |
| 05/28/2009 | WO2009065993A1 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-gmp synthesis obtained by said method |
| 05/28/2009 | WO2009065935A1 Polypeptides having acetylxylan esterase activity and polynucleotides encoding same |
| 05/28/2009 | WO2009065912A2 Plants having increased yield-related traits and a method for making the same |
| 05/28/2009 | WO2009065863A1 Maize with increased tolerance to fungal diseases |
| 05/28/2009 | WO2009065780A1 Dicarboxylic acid production in eukaryotes |
| 05/28/2009 | WO2009065779A1 Dicarboxylic acid production in a recombinant yeast |
| 05/28/2009 | WO2009065778A1 Succinic acid production in a eukaryotic cell |
| 05/28/2009 | WO2009065777A1 Dicarboxylic acid production in a filamentous fungus |
| 05/28/2009 | WO2009065618A2 Improvement of transfection results of non-viral gene delivery systems by influencing the congenital immune system |
| 05/28/2009 | WO2009065573A1 Bacteriophages and coating material for surfaces |
| 05/28/2009 | WO2009065547A2 Poxviral oncolytic vectors |
| 05/28/2009 | WO2009065301A1 Rice's non-endosperm tissue-specific expression promoter, ostsp i, and uses thereof |
| 05/28/2009 | WO2009065296A1 Gene engineering immunorepressive polypeptides and their preparing methods and uses |
| 05/28/2009 | WO2009065292A1 Fusion protein comprising tumor necrosis factor related apoptosis inducing ligand and integrin ligand and use thereof |
| 05/28/2009 | WO2009048966A3 Engineered dicotyledonous promoters capable of expressing in monocotyledonous plants |
| 05/28/2009 | WO2009040819A3 DOWN-REGULATION OF MORTALIN BY siRNA |
| 05/28/2009 | WO2009039173A3 SiRNA SEQUENCE-INDEPENDENT MODIFICATION FORMATS FOR REDUCING OFF-TARGET PHENOTYPIC EFFECTS IN RNAi, AND STABILIZED FORMS THEREOF |
| 05/28/2009 | WO2009038841A3 Portable, temperature and chemically inducible expression vector for high cell density expression of heterologous genes in escherichia coli |
| 05/28/2009 | WO2009037329A3 Plants with increased yield |
| 05/28/2009 | WO2009036933A9 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 05/28/2009 | WO2009029193A3 Peptides and proteins for early liver development and antibodies thereto |
| 05/28/2009 | WO2009027335A3 Polypeptides, such as lipases, capable of altering the seed storage content in transgenic plants |
| 05/28/2009 | WO2008152131A3 Rnai inhibition of alpha-enac expression |
| 05/28/2009 | WO2008130382A3 Fusion proteins comprising an anti -inflammatory cytokine and an antigen for treatment of immune disorders |
| 05/28/2009 | WO2008095066A3 Auto-regulated expression of bacterial isopentenyltransferase gene promotes t-dna transformaton in soybean |
| 05/28/2009 | WO2008087562A9 Methods and compositions for modulating the mirna pathway |
| 05/28/2009 | WO2007009069A3 Heat lysis production of proteins |
| 05/28/2009 | WO2007008732A3 Compositions and methods for suppressing axonal growth inhibition |
| 05/28/2009 | WO2006132966A3 Webbed hiv envelope immunogens, methods for production and use of same |
| 05/28/2009 | WO2006023248A3 Processes for producing and crystallizing g-protein coupled receptors |
| 05/28/2009 | WO2005030927A3 Methods and compositions for in vivo inflammation monitoring |
| 05/28/2009 | WO2005017112A3 Methods of inhibiting cancer growth by binding to nuclear receptors |
| 05/28/2009 | US20090138992 Limnanthes oil genes |
| 05/28/2009 | US20090138991 Plants having improved growth characteristics and method for making the same |
| 05/28/2009 | US20090138990 Methods and compositions to increase plant resistance to stress |
| 05/28/2009 | US20090138988 Modification of plant disease resistance |
| 05/28/2009 | US20090138987 expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress (drought, cold, oxidation) |
| 05/28/2009 | US20090138986 Regulatory Elements Associated with CBF Transcription Factors of Maize |
| 05/28/2009 | US20090138985 Methods for plant transformation using spectinomycin selection |
| 05/28/2009 | US20090138984 Genes involved in tolerance to environmental stress |
| 05/28/2009 | US20090138983 AtBG1 {Arabidopsis thaliana beta -glucosidase 1); plant having resistance to various environmental stresses by increasing the level of abscisic acid (ABA), stresses including low temperature, salt damage and dehydration owing to the increased level of ABA |
| 05/28/2009 | US20090138982 Lettuce cultivar 80-0601018-b |
| 05/28/2009 | US20090138981 Transcription factors incorporated into expression vectors, and ectopically expressed in plants; transgenic plants with disease resistance, and various other traits such as tolerance to heat, cold, drought, or low nutrient conditions, altered oil content, leaf phenotypes |
| 05/28/2009 | US20090138980 Novel tomato plants |
| 05/28/2009 | US20090138979 Manipulating sp1 activity to improve therapeutic cloning |
| 05/28/2009 | US20090138204 Single nucleotide polymorphisms sensitively predicting adverse drug reactions (ADR) and drug efficacy |
| 05/28/2009 | US20090137788 Nucleotide sequences coding bacterial cell surface proteins for use in generating monoclonal antibodies for prevention and treatment of infection |
| 05/28/2009 | US20090137782 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
| 05/28/2009 | US20090137778 A HIV peptide consisting of 23 to 50 amino acid residues; trans-activator |
| 05/28/2009 | US20090137759 Biochemical synthesis of 6-amino caproic acid |
| 05/28/2009 | US20090137519 represents phosphodiester or phosphodiester-like internucleotide linkage; for treating allergy, such as allergic rhinitis and asthma, cancer and hepatitis B and hepatitis C infectious diseases |
| 05/28/2009 | US20090137518 Therapeutic Antiangiogenic Endostatin Compositions |
| 05/28/2009 | US20090137517 Sensitizing a cell to cancer treatment by modulating the activity of a nucleic acid encoding rps27l protein |
| 05/28/2009 | US20090137514 Methods and compositions for silencing genes without inducing toxicity |
| 05/28/2009 | US20090137513 RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090137506 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 05/28/2009 | US20090137505 Method for Predicting and Identifying Target mRnas Controlled By Functional Rnas and Method of Using the Same |
| 05/28/2009 | US20090137504 Microrna target site blocking oligos and uses thereof |
| 05/28/2009 | US20090137502 Riproximin, a Novel Type II Ribosome-Inactivating Protein and Uses Thereof |
| 05/28/2009 | US20090137484 Neuronal Network-Interacting Peptide |
| 05/28/2009 | US20090137481 Antimicrobial polypeptides |
| 05/28/2009 | US20090137476 Apo-2 ligand variants and uses thereof |
| 05/28/2009 | US20090137472 Chimeric mhc protein and oligomer thereof |
| 05/28/2009 | US20090137471 Ngf variants |
| 05/28/2009 | US20090137468 Cytotoxic factors for modulating cell death |
| 05/28/2009 | US20090137465 Novel use |
| 05/28/2009 | US20090137427 Method for generating hypermutable organisms |
| 05/28/2009 | US20090137421 GENETIC SELECTION SYSTEM FOR IDENTIFICATION OF MicroRNA TARGET GENES |
| 05/28/2009 | US20090137412 Chromogenic in situ hybridization methods, kits, and compositions |